#august2020mccqe1
A 37-year-old man who is HIV-positive recently started on a highly active antiretroviral regimen. The patient’s CD4+ cell count subsequently fell below 200/mm3. Over the course of the next 3 months, he develops diarrhea and notices a redistribution of fat on his body. Which of the following agents is most likely causing this patient’s symptoms?
(A) Fusion inhibitor
(B) Non-nucleoside reverse transcriptase inhibitor
(C) Nucleoside reverse transcriptase inhibitor
(D) Nucleotide reverse transcriptase inhibitor
(E) Protease inhibitor
A 37-year-old man who is HIV-positive recently started on a highly active antiretroviral regimen. The patient’s CD4+ cell count subsequently fell below 200/mm3. Over the course of the next 3 months, he develops diarrhea and notices a redistribution of fat on his body. Which of the following agents is most likely causing this patient’s symptoms?
(A) Fusion inhibitor
(B) Non-nucleoside reverse transcriptase inhibitor
(C) Nucleoside reverse transcriptase inhibitor
(D) Nucleotide reverse transcriptase inhibitor
(E) Protease inhibitor
Last edited by a moderator: